|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/20 Fuse Medical, Inc. 10-K 12/31/19 75:7.3M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 819K
2: EX-10.21 Material Contract HTML 30K
3: EX-21.1 Subsidiaries List HTML 21K
4: EX-23.1 Consent of Experts or Counsel HTML 23K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
54: R1 Document and Entity Information HTML 83K
28: R2 Consolidated Balance Sheets HTML 100K
37: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K
74: R4 Consolidated Statements of Operations HTML 83K
55: R5 Consolidated Statement of Changes in Stockholders' HTML 63K
Equity
29: R6 Consolidated Statements of Cash Flows HTML 103K
38: R7 Nature of Operations HTML 38K
72: R8 Significant Accounting Policies HTML 111K
57: R9 CPM Acquisition HTML 29K
49: R10 Maxim Acquisition HTML 56K
67: R11 Property and Equipment HTML 49K
34: R12 Goodwill and Intangible Assets HTML 80K
23: R13 Revolving Line of Credit HTML 32K
50: R14 Notes Payable - Related Parties HTML 26K
68: R15 Commitments and Contingencies HTML 41K
35: R16 Stockholders' Equity HTML 137K
24: R17 Income Taxes HTML 150K
48: R18 Concentrations HTML 64K
69: R19 Related Party Transactions HTML 56K
45: R20 Subsequent Events HTML 28K
18: R21 Significant Accounting Policies (Policies) HTML 164K
61: R22 Significant Accounting Policies (Tables) HTML 75K
65: R23 Maxim Acquisition (Tables) HTML 50K
46: R24 Property and Equipment (Tables) HTML 49K
19: R25 Goodwill and Intangible Assets (Tables) HTML 81K
62: R26 Commitments and Contingencies (Tables) HTML 38K
66: R27 Stockholders' Equity (Tables) HTML 134K
47: R28 Income Taxes (Tables) HTML 150K
17: R29 Concentrations (Tables) HTML 71K
21: R30 Nature of Operations (Details Narrative) HTML 42K
33: R31 Significant Accounting Policies (Details HTML 87K
Narrative)
71: R32 Significant Accounting Policies - Error Identified HTML 43K
in Weighted Average Number of Shares Outstanding
Used in Calculation of Earnings per Share
(Details)
52: R33 Significant Accounting Policies - Estimated Useful HTML 32K
Lives of Assets (Details)
20: R34 Significant Accounting Policies - Schedule of HTML 30K
Revenue Differentiation (Details)
32: R35 CPM Acquisition (Details Narrative) HTML 54K
70: R36 Maxim Acquisition (Details Narrative) HTML 49K
51: R37 Maxim Acquisition - Schedule of Unaudited Pro HTML 37K
Forma Information (Details)
22: R38 Property and Equipment - Summary of Property and HTML 39K
Equipment (Details)
31: R39 Property and Equipment (Details Narrative) HTML 27K
15: R40 Goodwill and Intangible Assets - Schedule of HTML 49K
Goodwill and Other Intangible Assets (Details)
44: R41 Goodwill and Intangible Assets - (Details HTML 29K
Narrative)
64: R42 Goodwill and Intangible Assets - Schedule of HTML 39K
Future Amortization Expense Related to Finite-Live
Intangible Assets (Details)
60: R43 Revolving Line of Credit (Details Narrative) HTML 97K
14: R44 Notes Payable - Related Parties (Details HTML 45K
Narrative)
43: R45 Commitments and Contingencies (Details Narrative) HTML 39K
63: R46 Commitments and Contingencies - Summary of HTML 35K
Operating Leases (Details)
59: R47 Stockholders' Equity - Summary of Compensation HTML 41K
Expense for Stock Options Granted to Board
Members, Employees And Marketing Representatives
(Details)
16: R48 Stockholders' Equity (Details Narrative) HTML 39K
41: R49 Stockholders' Equity - Summary of Stock Option HTML 57K
Activity (Details)
36: R50 Stockholders' Equity - Summary of Restricted Stock HTML 44K
Awards Activity (Details)
27: R51 Income Taxes - Components of Income Tax Expense HTML 45K
(Benefit) (Details)
53: R52 Income Taxes - Significant Components of Deferred HTML 62K
Income Tax Assets and Liabilities (Details)
73: R53 Income Taxes (Details Narrative) HTML 39K
39: R54 Income Taxes - Reconciliation of Income Tax HTML 40K
Computed at U.S. Statutory Rate to Effective
Income Tax Rate (Details)
30: R55 Concentrations - Significant Customers with HTML 31K
Individual Percentage of Total Revenues Equaling
Ten Percent (10%) or Greater (Details)
56: R56 Concentrations - Significant Customers with HTML 31K
Concentration of Accounts Receivable Representing
Ten Percent (10%) or Greater of Accounts
Receivable (Details)
75: R57 Concentrations - Significant Customers with HTML 31K
Concentration of Accounts Receivable Representing
Ten Percent (10%) or Greater of Accounts
Receivable (Parenthetical) (Details)
40: R58 Concentrations - Significant Suppliers Represented HTML 35K
Ten Percent (10%) or Greater of Goods Purchased
(Details)
26: R59 Related Party Transactions (Details Narrative) HTML 100K
25: XML IDEA XML File -- Filing Summary XML 135K
42: EXCEL IDEA Workbook of Financial Reports XLSX 80K
8: EX-101.INS XBRL Instance -- fzmd-20191231 XML 1.81M
10: EX-101.CAL XBRL Calculations -- fzmd-20191231_cal XML 152K
11: EX-101.DEF XBRL Definitions -- fzmd-20191231_def XML 566K
12: EX-101.LAB XBRL Labels -- fzmd-20191231_lab XML 1.25M
13: EX-101.PRE XBRL Presentations -- fzmd-20191231_pre XML 935K
9: EX-101.SCH XBRL Schema -- fzmd-20191231 XSD 179K
58: ZIP XBRL Zipped Folder -- 0001564590-20-014068-xbrl Zip 147K
| ||||||||||||||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/30/20 | |||
| For Period end: | 12/31/19 | |||
| 12/31/18 | 10-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/14/23 Fuse Medical, Inc. 10-K 12/31/22 74:8.7M ActiveDisclosure/FA 3/31/22 Fuse Medical, Inc. 10-K 12/31/21 72:8.6M ActiveDisclosure/FA 3/31/21 Fuse Medical, Inc. 10-K 12/31/20 72:7.1M ActiveDisclosure/FA |